Emerald Finance’s Net Profit Grows by 120 Percent YoY in H1 FY26

Mumbai (Maharashtra) [India], October 16: Emerald Finance Limited (BSE: EMERALD), is a dynamic company offering a spectrum of financial products and services including its flagship Earned Wage Access (EWA)in India, announced its Unaudited Financial Results for Q2 FY26 & H1 FY26.

Q2 FY26 Key Standalone Financial Highlights

• Total Income of ₹ 4.89 Cr, YoY growth of 66.21%

• EBITDA of ₹ 4.37 Cr, YoY growth of 78.53%

• Net Profit of ₹ 2.98 Cr, YoY growth of 106.98%

• EPS of ₹ 0.86, YoY growth of 95.90%

Q2 FY26 Key Consolidated Financial Highlight

• Total Income of ₹ 6.91 Cr, YoY growth of 37.85%
• EBITDA of ₹ 5.42 Cr, YoY growth of 54.80%
• Net Profit of ₹ 3.60 Cr, YoY growth of 75.47%
• EPS of ₹ 1.04, YoY growth of 66.13%

H1 FY26 Key Standalone Financial Highlight

• Total Income of ₹ 9.63 Cr, YoY growth of 76.78%

• EBITDA of ₹ 8.34 Cr, YoY growth of 90.31%

• Net Profit of ₹ 5.61 Cr, YoY growth of 120.61%

• EPS of ₹ 1.62, YoY growth of 107.61%

H1 FY26 Key Consolidated Financial Highlight

• Total Income of ₹ 13.65 Cr, YoY growth of 45.04%
• EBITDA of ₹ 10.37 Cr, YoY growth of 60.79%
• Net Profit of ₹ 6.79 Cr, YoY growth of 80.56%
• EPS of ₹ 1.96, YoY growth of 70.73%

Comment on Financial Performance Mr. Sanjay Aggarwal, Managing Director of Emerald FinanceLimited said, “Q2 FY26 has been another strong quarter for Emerald Finance, reflecting sustained growth momentum across our key business segments. We have onboarded 145 corporates on our Earned Wage Access platform till date and successfully launched the ‘Emerald EWA’ mobile app on Google Play, further enhancing digital accessibility for our corporate partners and their employees. Our gold loan syndication business continued to gain strong traction, achieving disbursements of ₹115 + crore during Q2 FY26. This reflects the growing confidence of our partners and the scalability of our asset-light, technology-driven model.

India’s financial ecosystem continues to experience strong tailwinds, supported by digital adoption, rising formal credit penetration, and policy-driven inclusion initiatives. NBFCs and fintechs are at the forefront of this evolution, and Emerald is well positioned within this landscape through its technology-led, asset-light model and inclusive financial approach.”

Q2 FY26 Key Business Highlights

EWA App Launch • Launch: ‘EMERALD EWA’ on Google Play

• Access: For registered company and their employees only

• Purpose: Boosts digital services for corporate partners and their employees

Gold Loan Disbursement • Disbursement: Gold Loans of ₹115+ Cr in this quarter

• Entities: Emerald Finance Limited & subsidiary Eclat Net Advisors Private Limited

• Business: Under syndication business

Corporates Onboarded for EWA • Onboarding: 145 corporates onboarded as of now

• Employee Benefit: Employees can access a portion of earned salary anytime

• Repayment: Recovered through salary deductions

If you object to the content of this press release, please notify us at [email protected]. We will respond and rectify the situation within 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More